The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
The Ebola virus (EBOV) uses evasion mechanisms that directly interfere with host T-cell antiviral responses. By steric shielding of human leukocyte antigen class-1, the Ebola glycoprotein (GP) blocks interaction with T-cell receptors (TCRs), thus rendering T cells unable to attack virus-infected cel...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01428/full |
id |
doaj-eb7ada3b6b394490ba43790efa5efe92 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Avishay Edri Avishay Edri Avishai Shemesh Avishai Shemesh Muhammed Iraqi Muhammed Iraqi Omri Matalon Michael Brusilovsky Michael Brusilovsky Uzi Hadad Uzi Hadad Olga Radinsky Olga Radinsky Orly Gershoni-Yahalom Orly Gershoni-Yahalom John M. Dye Ofer Mandelboim Mira Barda-Saad Leslie Lobel Leslie Lobel Angel Porgador Angel Porgador |
spellingShingle |
Avishay Edri Avishay Edri Avishai Shemesh Avishai Shemesh Muhammed Iraqi Muhammed Iraqi Omri Matalon Michael Brusilovsky Michael Brusilovsky Uzi Hadad Uzi Hadad Olga Radinsky Olga Radinsky Orly Gershoni-Yahalom Orly Gershoni-Yahalom John M. Dye Ofer Mandelboim Mira Barda-Saad Leslie Lobel Leslie Lobel Angel Porgador Angel Porgador The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells Frontiers in Immunology Ebola GP Ebola modulation of immune system viral evasion strategies NKG2D MICA |
author_facet |
Avishay Edri Avishay Edri Avishai Shemesh Avishai Shemesh Muhammed Iraqi Muhammed Iraqi Omri Matalon Michael Brusilovsky Michael Brusilovsky Uzi Hadad Uzi Hadad Olga Radinsky Olga Radinsky Orly Gershoni-Yahalom Orly Gershoni-Yahalom John M. Dye Ofer Mandelboim Mira Barda-Saad Leslie Lobel Leslie Lobel Angel Porgador Angel Porgador |
author_sort |
Avishay Edri |
title |
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells |
title_short |
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells |
title_full |
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells |
title_fullStr |
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells |
title_full_unstemmed |
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells |
title_sort |
ebola-glycoprotein modulates the function of natural killer cells |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2018-07-01 |
description |
The Ebola virus (EBOV) uses evasion mechanisms that directly interfere with host T-cell antiviral responses. By steric shielding of human leukocyte antigen class-1, the Ebola glycoprotein (GP) blocks interaction with T-cell receptors (TCRs), thus rendering T cells unable to attack virus-infected cells. It is likely that this mechanism could promote increased natural killer (NK) cell activity against GP-expressing cells by preventing the engagement of NK inhibitory receptors; however, we found that primary human NK cells were less reactive to GP-expressing HEK293T cells. This was manifested as reduced cytokine secretion, a reduction in NK degranulation, and decreased lysis of GP-expressing target cells. We also demonstrated reduced recognition of GP-expressing cells by recombinant NKG2D and NKp30 receptors. In accordance, we showed a reduced monoclonal antibody-based staining of NKG2D and NKp30 ligands on GP-expressing target cells. Trypsin digestion of the membrane-associated GP led to a recovery of the recognition of membrane-associated NKG2D and NKp30 ligands. We further showed that membrane-associated GP did not shield recognition by KIR2DL receptors; in accordance, GP expression by target cells significantly perturbed signal transduction through activating, but not through inhibitory, receptors. Our results suggest a novel evasion mechanism employed by the EBOV to specifically avoid the NK cell immune response. |
topic |
Ebola GP Ebola modulation of immune system viral evasion strategies NKG2D MICA |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2018.01428/full |
work_keys_str_mv |
AT avishayedri theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT avishayedri theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT avishaishemesh theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT avishaishemesh theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT muhammediraqi theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT muhammediraqi theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT omrimatalon theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT michaelbrusilovsky theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT michaelbrusilovsky theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT uzihadad theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT uzihadad theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT olgaradinsky theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT olgaradinsky theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT orlygershoniyahalom theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT orlygershoniyahalom theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT johnmdye theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT ofermandelboim theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT mirabardasaad theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT leslielobel theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT leslielobel theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT angelporgador theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT angelporgador theebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT avishayedri ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT avishayedri ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT avishaishemesh ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT avishaishemesh ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT muhammediraqi ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT muhammediraqi ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT omrimatalon ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT michaelbrusilovsky ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT michaelbrusilovsky ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT uzihadad ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT uzihadad ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT olgaradinsky ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT olgaradinsky ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT orlygershoniyahalom ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT orlygershoniyahalom ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT johnmdye ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT ofermandelboim ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT mirabardasaad ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT leslielobel ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT leslielobel ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT angelporgador ebolaglycoproteinmodulatesthefunctionofnaturalkillercells AT angelporgador ebolaglycoproteinmodulatesthefunctionofnaturalkillercells |
_version_ |
1725740477755424768 |
spelling |
doaj-eb7ada3b6b394490ba43790efa5efe922020-11-24T22:30:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-07-01910.3389/fimmu.2018.01428368334The Ebola-Glycoprotein Modulates the Function of Natural Killer CellsAvishay Edri0Avishay Edri1Avishai Shemesh2Avishai Shemesh3Muhammed Iraqi4Muhammed Iraqi5Omri Matalon6Michael Brusilovsky7Michael Brusilovsky8Uzi Hadad9Uzi Hadad10Olga Radinsky11Olga Radinsky12Orly Gershoni-Yahalom13Orly Gershoni-Yahalom14John M. Dye15Ofer Mandelboim16Mira Barda-Saad17Leslie Lobel18Leslie Lobel19Angel Porgador20Angel Porgador21The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, IsraelThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelU.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, United StatesThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, Jerusalem, IsraelThe Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, IsraelThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelDepartment of Emerging and Reemerging Diseases and Special Pathogens Uganda Virus Research Institute (UVRI), Entebbe, UgandaThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, IsraelNational Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe Ebola virus (EBOV) uses evasion mechanisms that directly interfere with host T-cell antiviral responses. By steric shielding of human leukocyte antigen class-1, the Ebola glycoprotein (GP) blocks interaction with T-cell receptors (TCRs), thus rendering T cells unable to attack virus-infected cells. It is likely that this mechanism could promote increased natural killer (NK) cell activity against GP-expressing cells by preventing the engagement of NK inhibitory receptors; however, we found that primary human NK cells were less reactive to GP-expressing HEK293T cells. This was manifested as reduced cytokine secretion, a reduction in NK degranulation, and decreased lysis of GP-expressing target cells. We also demonstrated reduced recognition of GP-expressing cells by recombinant NKG2D and NKp30 receptors. In accordance, we showed a reduced monoclonal antibody-based staining of NKG2D and NKp30 ligands on GP-expressing target cells. Trypsin digestion of the membrane-associated GP led to a recovery of the recognition of membrane-associated NKG2D and NKp30 ligands. We further showed that membrane-associated GP did not shield recognition by KIR2DL receptors; in accordance, GP expression by target cells significantly perturbed signal transduction through activating, but not through inhibitory, receptors. Our results suggest a novel evasion mechanism employed by the EBOV to specifically avoid the NK cell immune response.https://www.frontiersin.org/article/10.3389/fimmu.2018.01428/fullEbola GPEbolamodulation of immune systemviral evasion strategiesNKG2DMICA |